InvestorsHub Logo
Followers 45
Posts 7620
Boards Moderated 0
Alias Born 03/18/2016

Re: GOIN/Green post# 77583

Friday, 03/31/2017 11:37:17 AM

Friday, March 31, 2017 11:37:17 AM

Post# of 203915
PART I - REGISTRATION INFORMATION

OWC Pharmaceutical Research Corp.
30 Shacham Street. P.O.B. 8324 Petach Tikva, Israel
Address of Principal Executive Office (Street and Number)
PART II - RULE 12b-25(b)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

[X] (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report on Form 10-K will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date.

PART III - NARRATIVE

The Registrant's annual report on Form 10-K could not be filed within the prescribed time period because the Registrant encountered delays in preparing its audited financial statements.